---Advertisement---

DCGI authorizes Bharat Biotech’s intranasal Covid-19 vaccine for emergency use

New Delhi: The Bharat Biotech on Tuesday got emergency use authorization from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine. This will be India’s first nasal vaccine for COVID-19. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a ‘Big boost’ to India’s fight against Covid-19. He took to Twitter […]

Edited By : Mayank Kasyap | Updated: Sep 7, 2022 16:47 IST
Share :
Bharat Biotech's Intranasal vaccine
Bharat Biotech's Intranasal vaccine

New Delhi: The Bharat Biotech on Tuesday got emergency use authorization from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.

This will be India’s first nasal vaccine for COVID-19. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a ‘Big boost’ to India’s fight against Covid-19.

He took to Twitter and said, “Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.”

Also Read: Rear seat occupants not wearing seat will be penalised: Gadkari

“This step will further strengthen our collective fight against the pandemic. India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership,” he added.

He also said that we will defeat Covid-19 with a science-driven approach. “With the science-driven approach and Sabka Prayas, we will defeat COVID-19,” he said.

Read More :- Latest India News
Click Here – Download The News 24 App

 

First published on: Sep 06, 2022 07:05 PM IST

Get Breaking News First and Latest Updates from India and around the world on News24. Follow News24 on Facebook, Twitter.

Related Story